Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Pujol, N; Mane, A; Berge, D; Mezquida, G; Amoretti, S; Perez, L; Gonzalez-Pinto, A; Barcones, F; Cuesta, MJ; Sanchez-Tomico, G; Vieta, E; Castro-Fornieles, J; Bernardo, M; Parellada, M; PEPs GRP.

Influence of BDNF and MTHFR polymorphisms on hippocampal volume in first-episode psychosis

Schizophrenia Research. 2020; 223: 345-352 Nº de citas: 11 [doi:10.1016/j.schres.2020.08.002]

Radua, J; Vieta, E; Shinohara, R; Kochunov, P; Quide, Y; Green, MJ; Weickert, CS; Weickert, T; Bruggemann, J; Kircher, T; Nenadic, I; Cairns, MJ; Seal, M; Schall, U; Henskens, F; Fullerton, JM; Mowry, B; Pantelis, C; Lenroot, R; Cropley, V; Loughland, C; Scott, R; Wolf, D; Satterthwaite, TD; Tan, YL; Sim, K; Piras, F; Spalletta, G; Banaj, N; Pomarol-Clotet, E; Solanes, A; Albajes-Eizagirre, A; Canales-Rodriguez, EJ; Sarro, S; Di Giorgio, A; Bertolino, A; Stablein, M; Oertel, V; Knochel, C; Borgwardt, S; du Plessis, S; Yun, JY; Kwon, JS; Dannlowski, U; Hahn, T; Grotegerd, D; Alloza, C; Arango, C; Janssen, J; Diaz-Caneja, C; Jiang, WH; Calhoun, V; Ehrlich, S; Yang, K; Cascella, NG; Takayanagi, Y; Sawa, A; Tomyshev, A; Lebedeva, I; Kaleda, V; Kirschner, M; Hoschl, C; Tomecek, D; Skoch, A; van Amelsvoort, T; Bakker, G; James, A; Preda, A; Weideman, A; Stein, DJ; Howells, F; Uhlmann, A; Temmingh, H; Lopez-Jaramillo, C; Diaz-Zuluaga, A; Fortea, L; Martinez-Heras, E; Solana, E; Llufriu, S; Jahanshad, N; Thompson, P; Turner, J; van Erp, T; ENIGMA Consortium Collaborators.

Increased power by harmonizing structural MRI site differences with the ComBat batch method in ENIGMA

NEUROIMAGE. 2020; 218: Nº de citas: 193 [doi:10.1016/j.neuroimage.2020.116956]

S?nchez-Guti?rrez, T; Rodr?guez-Toscano, E; Llorente, C; de la Serna, E; Moreno, C; Sugranyes, G; Romero, S; Calvo, A; Baeza, I; S?nchez-Gistau, V; Espliego, A; Castro-Fornieles, J; Moreno, D.

Neuropsychological, clinical and environmental predictors of severe mental disorders in offspring of patients with schizophrenia

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2020; 270(6): 739-748 Nº de citas: 10 [doi:10.1007/s00406-019-01044-7]

Caro-Canizares, I; Serrano-Drozdowskyj, E; Pfang, B; Baca-Garcia, E; Carballo, JJ.

SDQ Dysregulation Profile and Its Relation to the Severity of Psychopathology and Psychosocial Functioning in a Sample of Children and Adolescents With ADHD

Journal of Attention Disorders. 2020; 24(11): 1557-1564 Nº de citas: 15 [doi:10.1177/1087054717691829]

Moreno, C; Wykes, T; Galderisi, S; Nordentoft, M; Crossley, N; Jones, N; Cannon, M; Correll, CU; Byrne, L; Carr, S; Chen, EYH; Gorwood, P; Johnson, S; Karkkainen, H; Krystal, JH; Lee, J; Lieberman, J; Lopez-Jaramillo, C; Mannikko, M; Phillips, MR; Uchida, H; Vieta, E; Vita, A; Arango, C.

How mental health care should change as a consequence of the COVID-19 pandemic

Lancet Psychiatry. 2020; 7(9): 813-824 Nº de citas: 1001 [doi:10.1016/S2215-0366(20)30307-2]

Arango, C; Ng-Mak, D; Finn, E; Byrne, A; Loebel, A.

Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2020; 29(9): 1195-1205 Nº de citas: 31 [doi:10.1007/s00787-019-01425-2]

Siafis, S; Ciray, O; Schneider-Thoma, J; Bighelli, I; Krause, M; Rodolico, A; Ceraso, A; Deste, G; Huhn, M; Fraguas, D; Mavridis, D; Charman, T; Murphy, DG; Parellada, M; Arango, C; Leucht, S.

Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis

Molecular Autism. 2020; 11(1): Nº de citas: 53 [doi:10.1186/s13229-020-00372-z]

Deters, RK; Naaijen, J; Rosa, M; Aggensteiner, PM; Banaschewski, T; Saam, MC; Schulze, UME; Sethi, A; Craig, MC; Sagar-Ouriaghli, I; Santosh, P; Castro-Fornieles, J; Penzol, MJ; Arango, C; Werhahn, JE; Brandeis, D; Franke, B; Glennon, J; Buitelaar, JK; Hoekstra, PJ; Dietrich, A.

Executive functioning and emotion recognition in youth with oppositional defiant disorder and/or conduct disorder

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2020; 21(7): 539-551 Nº de citas: 27 [doi:10.1080/15622975.2020.1747114]

Boada, L; Lahera, G; Pina-Camacho, L; Merchan-Naranjo, J; Diaz-Caneja, CM; Bellon, JM; Ruiz-Vargas, JM; Parellada, M.

Social Cognition in Autism and Schizophrenia Spectrum Disorders: The Same but Different?

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS. 2020; 50(8): 3046-3059 Nº de citas: 29 [doi:10.1007/s10803-020-04408-4]

van Os, J; Pries, LK; Delespaul, P; Kenis, G; Luykx, JJ; Lin, BCD; Richards, AL; Akdede, B; Binbay, T; Altinyazar, V; Yalincetin, B; Gumus-Akay, G; Cihan, B; Soygur, H; Ulas, H; Cankurtaran, ES; Kaymak, SU; Mihaljevic, MM; Petrovic, SA; Mirjanic, T; Bernardo, M; Cabrera, B; Bobes, J; Saiz, PA; Garcia-Portilla, MP; Sanjuan, J; Aguilar, EJ; Santos, JL; Jimenez-Lopez, E; Arrojo, M; Carracedo, A; Lopez, G; Gonzalez-Penas, J; Parellada, M; Maric, NP; Atbasoglu, C; Ucok, A; Alptekin, K; Saka, MC; Arango, C; O'Donovan, M; Rutten, BPF; Guloksuz, S; Genetic Risk Outcome Investigators.

Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study

PSYCHOLOGICAL MEDICINE. 2020; 50(11): 1884-1897 Nº de citas: 34 [doi:10.1017/S003329171900196X]

Lei, D; Pinaya, WHL; van Amelsvoort, T; Marcelis, M; Donohoe, G; Mothersill, DO; Corvin, A; Gill, M; Vieira, S; Huang, XQ; Lui, S; Scarpazza, C; Young, J; Arango, C; Bullmore, E; Qiyong, G; McGuire, P; Mechelli, A.

Detecting schizophrenia at the level of the individual: relative diagnostic value of whole-brain images, connectome-wide functional connectivity and graph-based metrics

PSYCHOLOGICAL MEDICINE. 2020; 50(11): 1852-1861 Nº de citas: 61 [doi:10.1017/S0033291719001934]

Gonzalez-Penas, J; Costas, JC; Garcia-Alcon, A; Penzol, MJ; Rodriguez, J; Rodriguez-Fontenla, C; Alonso-Gonzalez, A; Fernandez-Prieto, M; Carracedo, A; Arango, C; Parellada, M.

Psychiatric comorbidities in Asperger syndrome are related with polygenic overlap and differ from other Autism subtypes

Translational Psychiatry. 2020; 10(1): Nº de citas: 14 [doi:10.1038/s41398-020-00939-7]

Tandon, R; Lenderking, WR; Weiss, C; Shalhoub, H; Barbosa, CD; Chen, J; Greene, M; Meehan, SR; Duvold, LB; Arango, C; Agid, O; Castle, D.

The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey

Annals of General Psychiatry. 2020; 19(1): Nº de citas: 61 [doi:10.1186/s12991-020-00292-5]

Berge, D; Mane, A; Lesh, TA; Bioque, M; Barcones, F; Gonzalez-Pinto, AM; Parellada, M; Vieta, E; Castro-Fornieles, J; Rodriguez-Jimenez, R; Garcia-Portilla, MP; Usall, J; Carter, CS; Cabrera, B; Bernardo, M; Janssen, J; Mezquida, G; Amoretti, S; Pina-Camacho, L; Arango, C; Gonzalez-Ortega, I; Garcia, S; De-la-Camara, C; Fayed, N; Sanjuan, J; Aguilar, EJ; Guo, JY; Salgado, P; Radua, J; Sanchez-Moreno, J; de la Serna, E; Baeza, I; Contreras-Fernandez, F; Saiz-Masvidal, C; Gonzalez-Blanco, L; Jimenez-Trevino, L; Dompablo, M; Torio, I; Butjosa, A; Rubio-Abadel, E; Sarro, S; Pomarol-Clotet, E; PEPs Grp Collaborators.

Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness

SCHIZOPHRENIA BULLETIN. 2020; 46(4): 846-856 Nº de citas: 16 [doi:10.1093/schbul/sbz132]

Mas, S; Boloc, D; Rodriguez, N; Mezquida, G; Amoretti, S; Cuesta, MJ; Gonzalez-Penas, J; Garcia-Alcon, A; Lobo, A; Gonzalez-Pinto, A; Corripio, I; Vieta, E; Castro-Fornieles, J; Mane, A; Saiz-Ruiz, J; Gasso, P; Bioque, M; Bernardo, M; PEPs Grp.

Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis Cohort

SCHIZOPHRENIA BULLETIN. 2020; 46(4): 1019-1025 Nº de citas: 36 [doi:10.1093/schbul/sbaa012]

Boloc, D; Rodriguez, N; Torres, T; Garcia-Cerro, S; Parellada, M; Saiz-Ruiz, J; Cuesta, MJ; Bernardo, M; Gasso, P; Lafuente, A; Mas, S; Arnaiz, JA.

Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms

PSYCHOPHARMACOLOGY. 2020; 237(7): 2151-2159 Nº de citas: 3 [doi:10.1007/s00213-020-05526-8]

Fusar-Poli, P; de Pablo, GS; Correll, CU; Meyer-Lindenberg, A; Millan, MJ; Borgwardt, S; Galderisi, S; Bechdolf, A; Pfennig, A; Kessing, LV; van Amelsvoort, T; Nieman, DH; Domschke, K; Krebs, MO; Koutsouleris, N; McGuire, P; Do, KQ; Arango, C.

Prevention of Psychosis Advances in Detection, Prognosis, and Intervention

JAMA Psychiatry. 2020; 77(7): 755-765 Nº de citas: 397 [doi:10.1001/jamapsychiatry.2019.4779]

Jongs, N; Jagesar, R; van Haren, NEM; Penninx, BWJH; Reus, L; Visser, PJ; van der Wee, NJA; Koning, IM; Arango, C; Sommer, IEC; Eijkemans, MJC; Vorstman, JA; Kas, MJ.

A framework for assessing neuropsychiatric phenotypes by using smartphone-based location data

Translational Psychiatry. 2020; 10(1): Nº de citas: 36 [doi:10.1038/s41398-020-00893-4]